Sign in
ICCC Stock Price, Chart, Stats & News
ImmuCell Corporation
Save
ImmuCell Corporation (ICCC) does not currently pay a dividend.
89.79M
Market cap
–
Current P/E
–
Forward P/E
ICCC chart
Fundamentals
Gross margin | 41.40% |
Operating margin | 5.97% |
Pretax margin | -3.72% |
Net margin | -3.76% |
Effective tax rate | -1.10% |
ROA | -2.44% |
ROE | -4.69% |
D/E | – |
Interest coverage ratio | 4.26x |
ICCC valuation
P/E | – |
P/S | 2.13x |
P/B | – |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | 0.40x |
EV multiple | 13.26x |
About
ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U. S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves.
Similar securities
Based on sector and market capitalization
Report issue